Response prediction and risk stratification of patients with rectal cancer after neoadjuvant therapy through an analysis of circulating tumour DNA.

Compared with baseline and in-process samples, a clear trend of a reduced post-NAT ctDNA fraction was observed in both the recurrence and nonrecurrence groups ( Figure 4 b), which highlighted the significant therapeutic effect of NAT.

also in 19,460 other papers